DATASHEET
Host:
Rabbit
Target Protein:
Prostaglandin E Receptor EP2
Immunogen Range:
271-358/358
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
5732
Swiss Prot:
P43116
Source:
KLH conjugated synthetic peptide derived from human Prostaglandin E Receptor EP2
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. The subsequent raise in intracellular cAMP is responsible for the relaxing effect of this receptor on smooth muscle.
PRODUCT SPECIFIC PUBLICATIONS
- Takemiya et al. Microsomal Prostaglandin E Synthase-1 Facilitates an Intercellular Interaction between CD4⁺ T Cells through IL-1β Autocrine Function in Experimental Autoimmune Encephalomyelitis. (2017) Int.J.Mol.Sci. 18 Read more>>
- Wu F et al. Manganese exposure caused reproductive toxicity of male mice involving activation of GnRH secretion in the hypothalamus by prostaglandin E2 receptors EP1 and EP2. Ecotoxicol Environ Saf. 2020 Sep 15;201:110712.Read more>>
VALIDATION IMAGES
Mouse spleen lysates probed with Anti-Prostaglandin E Receptor EP2 Polyclonal Antibody, Unconjugated (bs-4196R) at 1:300 in 4˚C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:5000 90min in RT.
A549 cells probed with Prostaglandin E Receptor EP2 Antibody, ALEXA FLUOR® 647 Conjugated (bs-4196R-A647) at 5ug for 30 minutes compared to control cells (blue) and isotype control (orange).
Lane 1: Mouse Spleen tissue lysates; Lane 2: Mouse Urinary bladder tissue lysates; Lane 3: Mouse Placenta tissue lysates; Lane 4: Rat Urinary bladder tissue lysates; Lane 5: Rat Placenta tissue lysates; Lane 6: Human MCF-7 cell lysates; Lane 7: Human JAR cell lysates; Lane 8: Human HL60 cell lysates probed with PTGER2 Polyclonal Antibody, Unconjugated (bs-4196R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.